[PHARMA] YoY Cumulative Quarter Result on 30-Sep-2009 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
13-Nov-2009
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
30-Sep-2009 [#3]
Profit Trend
QoQ- 18.81%
YoY- -9.38%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Revenue 1,329,942 1,153,195 1,002,232 976,890 977,403 891,166 790,927 9.03%
PBT 99,066 56,818 48,163 53,948 66,103 54,326 27,852 23.52%
Tax -28,392 -16,215 -15,901 -14,337 -22,616 -19,055 -10,643 17.74%
NP 70,674 40,603 32,262 39,611 43,487 35,271 17,209 26.51%
-
NP to SH 69,645 40,215 32,640 38,279 42,242 34,011 15,974 27.78%
-
Tax Rate 28.66% 28.54% 33.01% 26.58% 34.21% 35.08% 38.21% -
Total Cost 1,259,268 1,112,592 969,970 937,279 933,916 855,895 773,718 8.44%
-
Net Worth 496,623 464,307 424,715 407,610 374,390 335,831 323,006 7.42%
Dividend
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Div 29,420 - 50,281 28,885 19,254 16,042 12,299 15.63%
Div Payout % 42.24% - 154.05% 75.46% 45.58% 47.17% 77.00% -
Equity
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Net Worth 496,623 464,307 424,715 407,610 374,390 335,831 323,006 7.42%
NOSH 117,683 106,983 106,981 106,984 106,968 106,952 106,955 1.60%
Ratio Analysis
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
NP Margin 5.31% 3.52% 3.22% 4.05% 4.45% 3.96% 2.18% -
ROE 14.02% 8.66% 7.69% 9.39% 11.28% 10.13% 4.95% -
Per Share
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
RPS 1,130.10 1,077.92 936.83 913.11 913.73 833.23 739.49 7.31%
EPS 59.18 37.59 30.51 35.78 39.49 31.80 14.93 25.77%
DPS 25.00 0.00 47.00 27.00 18.00 15.00 11.50 13.80%
NAPS 4.22 4.34 3.97 3.81 3.50 3.14 3.02 5.72%
Adjusted Per Share Value based on latest NOSH - 107,049
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
RPS 92.28 80.01 69.54 67.78 67.82 61.83 54.88 9.03%
EPS 4.83 2.79 2.26 2.66 2.93 2.36 1.11 27.74%
DPS 2.04 0.00 3.49 2.00 1.34 1.11 0.85 15.69%
NAPS 0.3446 0.3222 0.2947 0.2828 0.2598 0.233 0.2241 7.42%
Price Multiplier on Financial Quarter End Date
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Date 28/09/12 30/09/11 30/09/10 30/09/09 30/09/08 28/09/07 29/09/06 -
Price 7.55 5.90 4.98 4.09 3.24 3.27 3.98 -
P/RPS 0.67 0.55 0.53 0.45 0.35 0.39 0.54 3.65%
P/EPS 12.76 15.70 16.32 11.43 8.20 10.28 26.65 -11.54%
EY 7.84 6.37 6.13 8.75 12.19 9.72 3.75 13.06%
DY 3.31 0.00 9.44 6.60 5.56 4.59 2.89 2.28%
P/NAPS 1.79 1.36 1.25 1.07 0.93 1.04 1.32 5.20%
Price Multiplier on Announcement Date
30/09/12 30/09/11 30/09/10 30/09/09 30/09/08 30/09/07 30/09/06 CAGR
Date 06/11/12 01/11/11 04/11/10 13/11/09 24/11/08 22/11/07 13/11/06 -
Price 8.25 5.90 4.92 3.93 3.35 3.42 3.65 -
P/RPS 0.73 0.55 0.53 0.43 0.37 0.41 0.49 6.86%
P/EPS 13.94 15.70 16.13 10.98 8.48 10.75 24.44 -8.92%
EY 7.17 6.37 6.20 9.10 11.79 9.30 4.09 9.79%
DY 3.03 0.00 9.55 6.87 5.37 4.39 3.15 -0.64%
P/NAPS 1.95 1.36 1.24 1.03 0.96 1.09 1.21 8.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment